TAB2は,TNF経路のTNFR1複合体IIレベルでのTAK1独立の細胞死チェックポイントを制御する
Tom Delanghe1,2, Mike Vadi1,2, Annelore Haems1,2
1VIB Center for Inflammation Research, 9052, Ghent, Belgium.
Cell death and differentiation
|September 1, 2025
まとめ
腫瘍死因 (TNF) 信号は細胞の運命を制御する. TAB2は,TAK1とは独立して重要な細胞死チェックポイントとして作用し,細胞毒性複合体の形成を制限することによって,アポトーシスと死滅を抑制します.
科学分野:
- 細胞生物学
- 免疫学
- 分子生物学
背景:
- 腫瘍死因 (TNF) 信号は細胞の運命を決定し,アポトーシス,ネクロプトーシス,そしてピロプトーシスのような生存と死亡の経路をバランスさせます.
- 調節不良のTNF誘発細胞死は炎症性疾患に寄与し,その調節メカニズムを理解する必要性を強調しています.
研究 の 目的:
- TNF媒介による細胞死経路における TAB2 適応タンパク質の役割を調査する.
- 細胞生存と死亡を調節する TAB2 の TAK1 独立機能を解明する.
主な方法:
- TNF信号伝達経路における TAB2欠乏細胞の分析
- TAB2とTNFR1複合体IIの相互作用を調査する.
- TAB2 NZFドメインの変異体を使って,細胞死亡の調節におけるその役割を評価する.
主要な成果:
- TAK1の活性化とは無関係に TNF誘発のアポトーシスを促進する.
- TAB2はTNFR1複合体IIの成分であり,細胞毒複合体の形成を制限する.
- TAB2のユビキチン結合NZFドメインは,アポプトーシスとネクロプトーシスを抑制するために不可欠です.
結論:
- TAB2はTNFシグナル伝達における新しい細胞死チェックポイントとして機能する.
- TAB2の生存促進の役割は,TAK1の活性化におけるその既知の機能とは独立している.
- TAB2は,そのNZFドメインを使用して,細胞毒性複合体の形成を制限し,それによってTNF誘発の細胞死を抑制します.
関連する概念動画
01:31The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
01:17The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
02:26NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
01:16TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
01:23Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K